PATENTS
Application for declaration November 10, 2003 letter from Apotex Inc. not notice of allegation (NOA) as contemplated by Patented Medicines (Notice of Compliance) Regulations or for order prohibiting Minister of Health from issuing notice of compliance to Apotex in respect of ramipril oral capsules until after expiration of Canadian Patent 1246457—Construction of patent—Issues: abuse of process, sufficiency of NOA, burden and standard of proof, invalidity of patent based on anticipation, obviousness, double patenting—Application dismissed—Patented Medicines (Notice of Compliance) Regulations, SOR/93‑133.
Aventis Pharma Inc. v. Apotex Inc. (T‑2459‑03, 2005 FC 1504, Tremblay‑Lamer J., order dated 4/11/05, 53 pp.)
You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.